BioMarin Pharmaceutical Inc. (BMRN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 348 |
| % of all portfolios: | 0.039% |
| Hold Price * : | $70.29 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q3 2024 | |||||
| ≡ | Torray Funds | Sell 100.00% | 16,855 | 0.21 | |
| Q1 2024 | |||||
| ≡ | Daniel Loeb - Third Point | Sell 100.00% | 385,000 | 0.56 | |
| Q1 2023 | |||||
| ≡ | Viking Global Investors | Reduce 58.88% | 3,105,003 | 1.42 | |
| Q4 2022 | |||||
| ≡ | Torray Funds | Reduce 4.12% | 466 | 0.01 | |
| ≡ | Dodge & Cox | Reduce 1.89% | 170,400 | 0.02 | |
| Q3 2022 | |||||
| ≡ | Torray Funds | Reduce 2.33% | 269 | 0.00 | |
| Q2 2022 | |||||
| ≡ | Torray Funds | Reduce 0.16% | 18 | 0.00 | |
| Q1 2022 | |||||
| ≡ | Torray Funds | Reduce 5.31% | 650 | 0.01 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 5,833 | 0.00 | |
| ≡ | Torray Funds | Reduce 25.40% | 4,166 | 0.05 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 9.98% | 647 | 0.00 | |
| Q1 2021 | |||||
| ≡ | Torray Funds | Reduce 75.72% | 50,070 | 0.59 | |
| Q4 2020 | |||||
| ≡ | Torray Funds | Reduce 3.31% | 2,263 | 0.03 | |
| Q2 2020 | |||||
| ≡ | Dodge & Cox | Reduce 7.73% | 195,000 | 0.04 | |
| ≡ | Torray Funds | Reduce 10.69% | 6,472 | 0.15 | |
| ≡ | Viking Global Investors | Sell 100.00% | 1,453,625 | 0.64 | |
| Q1 2020 | |||||
| ≡ | Dodge & Cox | Reduce 14.71% | 435,000 | 0.07 | |
| ≡ | Viking Global Investors | Reduce 10.37% | 168,114 | 0.07 | |
| Q4 2019 | |||||
| ≡ | Viking Global Investors | Reduce 46.97% | 1,436,365 | 0.57 | |
| ≡ | Torray Funds | Reduce 72.02% | 145,450 | 2.11 | |
| Q2 2019 | |||||
| ≡ | Torray Funds | Reduce 8.67% | 19,086 | 0.17 | |
| ≡ | Viking Global Investors | Reduce 49.50% | 2,538,558 | 0.98 | |
| Q1 2019 | |||||
| ≡ | Torray Funds | Reduce 2.03% | 4,552 | 0.04 | |
| Q4 2018 | |||||
| ≡ | Torray Funds | Reduce 5.32% | 12,632 | 0.13 | |
| Q2 2013 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 40,700 | 0.38 | |
| Q1 2013 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 69.03% | 90,700 | 0.85 | |
| Q4 2012 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 60.99% | 205,400 | 1.63 | |
| Q1 2012 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 3.51% | 11,200 | 0.06 | |
| Q4 2011 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 8.49% | 29,600 | 0.15 | |
| Q1 2011 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 51.54% | 371,000 | 1.07 | |
| Q3 2010 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 9.56% | 76,100 | 0.21 | |
| Q2 2009 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Sell 100.00% | 104,856 | 0.02 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.